Literature DB >> 9740619

Differences in tissue angiotensin II-forming pathways by species and organs in vitro.

M Akasu1, H Urata, A Kinoshita, M Sasaguri, M Ideishi, K Arakawa.   

Abstract

Angiotensin (Ang) II plays an important role in cardiovascular homeostasis, not only in the systemic circulation but also at the tissue level, and is involved in the remodeling of the heart and vasculature under pathological conditions. Although alternative Ang II-forming pathways are known to exist in various tissues, the details of such pathways remain unclear. The aim of this study was to examine tissue Ang II-forming activities and to identify the responsible enzyme in several organs (lung, heart, and aorta) in various species (human, hamster, rat, rabbit, dog, pig, and marmoset). Among the organs examined, the lung contained the highest Ang II-forming activity. The responsible enzyme for pulmonary Ang II formation was angiotensin I-converting enzyme (ACE) in all of the species except the human lung, in which a chymaselike enzyme was dominant. In the heart, the highest total Ang II-forming activity was observed in humans, and a chymaselike enzyme was dominant in all of the species except rabbit and pig. Aorta exhibited a relatively high total Ang II-forming activity, with a predominance of chymaselike activity in all of the species except rabbit and pig, in which ACE was dominant. Our results indicate that there were remarkable differences in Ang II-forming pathways among the species and organs we examined. To study the pathophysiological roles of ACE-independent Ang II formation, one should choose species and/or organs that have Ang II-forming pathways similar to those in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740619     DOI: 10.1161/01.hyp.32.3.514

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  23 in total

Review 1.  Angiotensin converting enzyme inhibition: from viper to patient.

Authors:  M Komajda; M C Wimart
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Enzymatic pathways involved in the generation of endothelin-1(1-31) from exogenous big endothelin-1 in the rabbit aorta.

Authors:  Carlos R Tirapelli; Marie-Helene Fecteau; Jean-Claude Honore; Eurode Legros; Fernand Gobeil; Pedro D'Orleans-Juste
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

3.  Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.

Authors:  Chih-Chang Wei; Naoki Hase; Yukiko Inoue; Eddie W Bradley; Eiji Yahiro; Ming Li; Nawazish Naqvi; Pamela C Powell; Ke Shi; Yoshimasa Takahashi; Keijiro Saku; Hidenori Urata; Louis J Dell'italia; Ahsan Husain
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

4.  ACE inhibitors to block MMP-9 activity: new functions for old inhibitors.

Authors:  Yufang Jin; Hai-Chao Han; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2007-09-12       Impact factor: 5.000

5.  Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivo.

Authors:  A Alvarez; L Piqueras; R Bello; A Canet; L Moreno; P Kubes; M J Sanz
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

6.  Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.

Authors:  Mingyi Wang; Jing Zhang; Gaia Spinetti; Li-Qun Jiang; Robert Monticone; Di Zhao; Linda Cheng; Melissa Krawczyk; Mark Talan; Gianfranco Pintus; Edward G Lakatta
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

7.  Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.

Authors:  J C Xiu; P Wu; J P Xu; Z Guo; W Lai; Y Zhang; S Li; J Li; Y Liu
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

Review 8.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.

Authors:  Yanwen Qin; Guo-Ping Shi
Journal:  Pharmacol Ther       Date:  2011-05-12       Impact factor: 12.310

9.  Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.

Authors:  W R Ford; A S Clanachan; C R Hiley; B I Jugdutt
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

10.  Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.

Authors:  Ming Li; Ke Liu; Jan Michalicek; James A Angus; John E Hunt; Louis J Dell'Italia; Michael P Feneley; Robert M Graham; Ahsan Husain
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.